Prostate Cell News 11.04 February 7, 2020 | |
| |
TOP STORYIdentification of a Zeb1 Expressing Basal Stem Cell Subpopulation in the Prostate Zeb1+ prostate epithelial cells were multipotent prostate basal stem cells that self-renewed and generated functional prostatic glandular structures at the single-cell level. [Nat Commun] Full Article | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Scientists compounded propranolol-conjugated superparamagnetic iron oxide nerve peptide nanoparticles, which achieved the nerve density visualization of prostate cancer with high sensitivity and high specificity. [Sci Adv] Full Article TIP5 Primes Prostate Luminal Cells for the Oncogenic Transformation Mediated by PTEN-Loss Researchers established an in vitro mouse prostate cancer model based on organoid technology that takes into account the cell of origin and the order of events. [Proc Natl Acad Sci USA] Abstract RNA-Seq Reveals Novel Mechanistic Targets of Withaferin A in Prostate Cancer Cells Scientists performed RNA-seq analysis using the 22Rv1 human prostate cancer cell line to identify mechanistic targets of Withaferin A. [Carcinogenesis] Abstract Blood Platelets Stimulate Cancer Extravasation through TGFβ-Mediated Downregulation of PRH/HHEX Investigators showed that depletion of proline-rich homeodomain (PRH) in immortalized prostate epithelial cells resulted in increased extravasation in vitro. [Oncogenesis] Full Article Induction of Tryptophan Hydroxylase in the Liver of Subcutaneous Tumor Model of Prostate Cancer The authors evaluated tryptophan catabolism in both tumor and peripheral tissues using tumor-engrafted Copenhagen rats that were subcutaneously inoculated with AT-2 rat prostate cancer cells. [Cancer Sci] Abstract Three vibrational spectroscopy techniques were applied for subcellular chemical imaging of cholesteryl esters in PC-3 prostate cancer cells. [J Biophotonics] Abstract Scientists intended to elucidate the antitumor efficacy of proxalutamide through the metabolomic profiling of prostate cancer (PCa) cells. Two androgen receptor (AR)-positive PCa cell lines and two AR-negative PCa cell lines were investigated. [Invest New Drugs] Abstract Overexpression of prostate-associated gene 4 (PAGE4) in a stromal cell line inhibited the migration and invasion of prostate cancer epithelial cells in multiple coculture systems. [J Cell Biochem] Abstract QW07 bound to androgen receptor (AR)-N-terminal domain (NTD) directly, blocked the transactivation of AR-NTD, and inhibited prostate cancer growth in vitro and in vivo. [Cell Biol Toxicol] Abstract Scientists investigated the anti-cancer effects and mechanism of action of EPA on PC3 prostate cancer cells in vitro. [Lipids Health Dis] Full Article Subscribe to one of our other 19 science newsletters such as Mammary Cell News & ESC & iPSC News. | |
| |
REVIEWSThe authors describe emerging approaches using primary prostate epithelial cells and prostate organoids and their genetic manipulation for disease modeling. [Int J Mol Sci] Full Article Visit our reviews page to see a complete list of reviews in the prostate cell research field. | |
| |
INDUSTRY NEWSArtelo Biosciences, Inc. announced that the National Cancer Institute (NCI) has awarded Stony Brook University a $4.2 million grant to advance the development of its fatty acid binding protein 5 (FABP5) inhibitor platform. [Artelo Biosciences, Inc.] Press Release Nanospectra Biosciences Initiates Pivotal Study of AuroLase Therapy for Ablation of Prostate Tissue Nanospectra Biosciences, Inc. announced the start of a pivotal study to determine the efficacy of using MRI/US fusion imaging technology to direct focal ablation of prostate tissue using nanoparticle-directed laser ablation. [Nanospectra Biosciences, Inc.] Press Release | |
| |
POLICY NEWSEx-Emory Scientist with Ties to China Charged with Fraud A former Emory University neuroscientist has been charged with defrauding the US government by taking a salary from a Chinese institution while also being paid through research grants from the National Institutes of Health. The charges against Li Xiao-Jiang were filed on 21 November 2019 in US district court in Atlanta and were first reported by NBC News. [ScienceInsider] Editorial US Prosecutor Leading China Probe Explains Effort That Led to Charges against Harvard Chemist The US government isn’t prosecuting Charles Lieber because he’s a world-renowned inorganic chemist at Harvard University, says the US attorney who last week drew headlines by charging Lieber with making false statements about his ties to Chinese research institutions. Nor does the Department of Justice think for one minute that Lieber is a spy. [ScienceInsider] Editorial
| |
EVENTSNEW American Association for Cancer Research (AACR) Annual Meeting 2020 Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Postdoctoral Research Associate – Cancer Development (University of Cambridge) Postdoctoral Fellow – Prostate Tumorigenesis (University of Cincinnati) Postdoctoral Fellow – RNA Splicing in Cancer (The University of Texas MD Anderson Cancer Center) Postdoctoral Position – Organoid Models of Prostate Cancer (University of Freiburg) Research Fellow – Anti-Cancer Therapy (Mayo Clinic) Postdoctoral Position – Cancer Cell Competition (Albert Einstein College of Medicine) Postdoctoral Fellow – Cancer Biology (City of Hope) Postdoctoral Fellow – Translational Cancer Research (University of New Mexico) Postdoctoral Researcher – Chromatin Structures in Cancer Cell States (Medical University of GdaÅ„sk) Tenure-Track Faculty Scientist Position – Radiation Oncology (New York University) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Prostate Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|